Arid
DOI10.1016/j.jchromb.2009.04.006
Elimination of diastereomer interference to determine Telcagepant (MK-0974) in human plasma using on-line turbulent-flow technology and off-line solid-phase extraction coupled with liquid chromatography/tandem mass spectrometry
Xu, Yang; Willson, Kenneth J.; Anderson, Melanie D. G.; Musson, Donald G.; Miller-Stein, Cynthia M.; Woolf, Eric J.
通讯作者Xu, Yang
来源期刊JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
ISSN1570-0232
出版年2009
卷号877期号:16-17页码:1634-1642
英文摘要

To eliminate the diastereomer interference on Telcagepant (MK-0974) determination during clinical study support, on-line high turbulent-flow liquid chromatography (HTLC) methods, HTLC-A and HTLC-B that covered dynamic range of 0.5-500 nM and 5-5000 nM, respectively, were developed. To meet the requirement of rapid assay transfer among multiple laboratories and analysts, a solid-phase extraction (SPE) assay was derived from the existing HTLC-B assay under the same dynamic range. The on-line HTLC assays were achieved through direct injection of plasma samples, extraction of analyte with a Cohesive C(18) column (50 mm x 0.5 mm, 50 mu m), followed by HPLC separation on a FluoPhase RP column (100 mm x 2.1 mm, 5 mu m) and MS/MS detection. The off-line SPE assay used Waters Oasis (R) HLB mu Elution plate to extract the analytes from plasma matrix before injecting on a FluoPhase RP column (150 mm x 2.1 mm, 5 mu m) for LC-MS/MS analysis. Under both on-line and off-line assay conditions, the diastereomer 1c was chromatographically separated from MK-0974. Cross-validation with the pooled samples demonstrated that both on-line and off-line assays provided comparable data with a difference of <2.6%. The assays were proved to be specific, accurate and reliable, and have been used to support multiple clinical studies. The pros and cons of on-line and off-line assays with regard to man power involved in sample preparation, total analysis time, carryover, cost efficiency, and the requirement for assay transfer are discussed. (C) 2009 Elsevier B.V. All rights reserved.


英文关键词Telcagepant MK-0974 CGRP receptor antagonist Diastereomer On-line extraction High turbulent-flow liquid chromatography (HTLC) Off-line solid-phase extraction (SPE) Human plasma
类型Article
语种英语
国家USA
收录类别SCI-E
WOS记录号WOS:000266687600004
WOS关键词URINE ; ANTAGONIST
WOS类目Biochemical Research Methods ; Chemistry, Analytical
WOS研究方向Biochemistry & Molecular Biology ; Chemistry
资源类型期刊论文
条目标识符http://119.78.100.177/qdio/handle/2XILL650/161437
作者单位Merck Res Labs, Clin PKPD, Dept Drug Metab, West Point, PA 19486 USA
推荐引用方式
GB/T 7714
Xu, Yang,Willson, Kenneth J.,Anderson, Melanie D. G.,et al. Elimination of diastereomer interference to determine Telcagepant (MK-0974) in human plasma using on-line turbulent-flow technology and off-line solid-phase extraction coupled with liquid chromatography/tandem mass spectrometry[J],2009,877(16-17):1634-1642.
APA Xu, Yang,Willson, Kenneth J.,Anderson, Melanie D. G.,Musson, Donald G.,Miller-Stein, Cynthia M.,&Woolf, Eric J..(2009).Elimination of diastereomer interference to determine Telcagepant (MK-0974) in human plasma using on-line turbulent-flow technology and off-line solid-phase extraction coupled with liquid chromatography/tandem mass spectrometry.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES,877(16-17),1634-1642.
MLA Xu, Yang,et al."Elimination of diastereomer interference to determine Telcagepant (MK-0974) in human plasma using on-line turbulent-flow technology and off-line solid-phase extraction coupled with liquid chromatography/tandem mass spectrometry".JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 877.16-17(2009):1634-1642.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xu, Yang]的文章
[Willson, Kenneth J.]的文章
[Anderson, Melanie D. G.]的文章
百度学术
百度学术中相似的文章
[Xu, Yang]的文章
[Willson, Kenneth J.]的文章
[Anderson, Melanie D. G.]的文章
必应学术
必应学术中相似的文章
[Xu, Yang]的文章
[Willson, Kenneth J.]的文章
[Anderson, Melanie D. G.]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。